Loading
Latest filing published 06 Dec 2022 for Eterna Therapeutics Inc., €221k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Filings by Nicholas Jason Singer span 2 companies, the busiest being Ernexa Therapeutics Inc. and OTR Acquisition Corp. The record holds 2 filings, for trades running from 20 May 2022 to 2 December 2022.
No open-market sale appears; the market trades are 1 purchase worth €221k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The newest entry dates from 6 December 2022: an open-market purchase of €221k, in Ernexa Therapeutics Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations